Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumors.
Li J, Xu Y, Zang A, Gao Y, Gao Q, Zhang Y, Wang D, Xu J, Yuan Y, Jiang H, Ying J, Shi C, Deng Y, Wang J, Liu T, Huang Y, Qian X, Pan Y, Cheng Y, Hu S, Wang J, Shi M, Wang K, Hu H, Shen L.
Li J, et al. Among authors: shen l.
Chin J Cancer Res. 2024 Jun 30;36(3):257-269. doi: 10.21147/j.issn.1000-9604.2024.03.03.
Chin J Cancer Res. 2024.
PMID: 38988490
Free PMC article.